Atrial Fibrillation (AFIB) in the ICU: Incidence, Risk Factors, and Outcomes: The International AFIB-ICU Cohort Study
- PMID: 37078722
- DOI: 10.1097/CCM.0000000000005883
Atrial Fibrillation (AFIB) in the ICU: Incidence, Risk Factors, and Outcomes: The International AFIB-ICU Cohort Study
Abstract
Objectives: To assess the incidence, risk factors, and outcomes of atrial fibrillation (AF) in the ICU and to describe current practice in the management of AF.
Design: Multicenter, prospective, inception cohort study.
Setting: Forty-four ICUs in 12 countries in four geographical regions.
Subjects: Adult, acutely admitted ICU patients without a history of persistent/permanent AF or recent cardiac surgery were enrolled; inception periods were from October 2020 to June 2021.
Interventions: None.
Measurements and main results: We included 1,423 ICU patients and analyzed 1,415 (99.4%), among whom 221 patients had 539 episodes of AF. Most (59%) episodes were diagnosed with continuous electrocardiogram monitoring. The incidence of AF was 15.6% (95% CI, 13.8-17.6), of which newly developed AF was 13.3% (11.5-15.1). A history of arterial hypertension, paroxysmal AF, sepsis, or high disease severity at ICU admission was associated with AF. Used interventions to manage AF were fluid bolus 19% (95% CI 16-23), magnesium 16% (13-20), potassium 15% (12-19), amiodarone 51% (47-55), beta-1 selective blockers 34% (30-38), calcium channel blockers 4% (2-6), digoxin 16% (12-19), and direct current cardioversion in 4% (2-6). Patients with AF had more ischemic, thromboembolic (13.6% vs 7.9%), and severe bleeding events (5.9% vs 2.1%), and higher mortality (41.2% vs 25.2%) than those without AF. The adjusted cause-specific hazard ratio for 90-day mortality by AF was 1.38 (95% CI, 0.95-1.99).
Conclusions: In ICU patients, AF occurred in one of six and was associated with different conditions. AF was associated with worse outcomes while not statistically significantly associated with 90-day mortality in the adjusted analyses. We observed variations in the diagnostic and management strategies for AF.
Copyright © 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Conflict of interest statement
The Department of Intensive Care, Rigshospitalet, has received funds for other research projects from the Novo Nordisk Foundation, Sygeforsikringen “danmark,” Pfizer, and Fresenius Kabi, and does contract research for AM-Pharma. The Department of Intensive Care, Copenhagen University Hospital—North Zealand, has received funds for other research projects from the Novo Nordisk Foundation, Sygeforsikringen “danmark,” and other foundations and does contract research for AM-Pharma and Inotrem. Dr. Bestle has received consultancy fee from AM-Pharma. Dr. Wetterslev received funding from The Research Council of Rigshospitalet, The Ehrenreich’s Foundation, and The Danish Society of Anesthesiology and Intensive Care Medicine; he received support for article research from The Research Council of Rigshospitalet, Copenhagen, Denmark. Drs. Granholm’s and Bestle’s institutions received funding from Sygeforsikringen. Dr. Granholm’s institution received funding from The Ehrenreich’s Foundation, the Novo Nordisk Foundation, Pfizer, Fresenius Kabi, and AM-Pharma. Drs. Shen, Gao, and Yang disclosed work for hire. Dr. Bestle received funding from AM-Pharma. Dr. Haranath received funding from Medvarsity. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment in
-
"Irregularly Irregular" - The Patterns, Challenges, and Outcomes of Atrial Fibrillation in the ICU.Crit Care Med. 2023 Sep 1;51(9):1255-1257. doi: 10.1097/CCM.0000000000005917. Epub 2023 Aug 17. Crit Care Med. 2023. PMID: 37589515 No abstract available.
Similar articles
-
New-onset atrial fibrillation in the intensive care unit: Protocol for an international inception cohort study (AFIB-ICU).Acta Anaesthesiol Scand. 2021 Jul;65(6):846-851. doi: 10.1111/aas.13827. Epub 2021 Apr 23. Acta Anaesthesiol Scand. 2021. PMID: 33864378
-
Incidence and predictors of new-onset atrial fibrillation in noncardiac intensive care unit patients.J Crit Care. 2014 Aug;29(4):697.e1-5. doi: 10.1016/j.jcrc.2014.03.029. Epub 2014 Apr 4. J Crit Care. 2014. PMID: 24814972
-
[Atrial fibrillation in medical intensive care unit patients: characteristics and consequences].Harefuah. 2013 Sep;152(9):520-3, 564. Harefuah. 2013. PMID: 24364091 Hebrew.
-
Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.Ann Pharmacother. 1997 Nov;31(11):1347-59. doi: 10.1177/106002809703101113. Ann Pharmacother. 1997. PMID: 9391691 Review.
-
Management of the older person with atrial fibrillation.J Gerontol A Biol Sci Med Sci. 2002 Jun;57(6):M352-63. doi: 10.1093/gerona/57.6.m352. J Gerontol A Biol Sci Med Sci. 2002. PMID: 12023264 Review.
Cited by
-
Machine learning in the prediction and detection of new-onset atrial fibrillation in ICU: a systematic review.J Anesth. 2024 Jun;38(3):301-308. doi: 10.1007/s00540-024-03316-6. Epub 2024 Apr 9. J Anesth. 2024. PMID: 38594589 Free PMC article.
-
The hospital frailty risk score effectively predicts adverse outcomes in patients with atrial fibrillation in the intensive care unit.Res Sq [Preprint]. 2024 May 16:rs.3.rs-4368526. doi: 10.21203/rs.3.rs-4368526/v1. Res Sq. 2024. PMID: 38798658 Free PMC article. Preprint.
-
Prognostic value of glycaemic variability for mortality in critically ill atrial fibrillation patients and mortality prediction model using machine learning.Cardiovasc Diabetol. 2024 Nov 26;23(1):426. doi: 10.1186/s12933-024-02521-7. Cardiovasc Diabetol. 2024. PMID: 39593120 Free PMC article.
-
Atrial fibrillation in critical illness: state of the art.Intensive Care Med. 2025 May;51(5):904-916. doi: 10.1007/s00134-025-07895-0. Epub 2025 May 5. Intensive Care Med. 2025. PMID: 40323451 Review.
-
Atrial fibrillation is not an independent determinant of 28-day mortality among critically III sepsis patients.BMC Anesthesiol. 2023 Oct 6;23(1):336. doi: 10.1186/s12871-023-02281-z. BMC Anesthesiol. 2023. PMID: 37803320 Free PMC article.
References
-
- Chugh SS, Roth GA, Gillum RF, et al.: Global burden of atrial fibrillation in developed and developing nations. Glob Heart. 2014; 9:113–119
-
- Hindricks G, Potpara T, Dagres N, et al.; ESC Scientific Document Group: 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42:373–498
-
- Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke. 1991; 22:983–988
-
- Odutayo A, Wong CX, Hsiao AJ, et al.: Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: Systematic review and meta-analysis. BMJ. 2016; 354:i4482
-
- Clark DM, Plumb VJ, Epstein AE, et al.: Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997; 30:1039–1045
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical